Systemic mastocytosis associated with t(8;21)(q22;q22) acute myeloid leukemia

Although KIT mutations are present in 20–25% of cases of t(8;21)(q22;q22) acute myeloid leukemia (AML), concurrent development of systemic mastocytosis (SM) is exceedingly rare. We examined the clinicopathologic features of SM associated with t(8;21)(q22;q22) AML in ten patients (six from our instit...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Pullarkat, Sheeja T., Pullarkat, Vinod, Kroft, Steven H., Wilson, Carla S., Ahsanuddin, Arshad N., Mann, Karen P., Thein, Maung, Grody, Wayne W., Brynes, Russell K.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer-Verlag 2009
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2713498/
https://ncbi.nlm.nih.gov/pubmed/19669220
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12308-009-0023-2
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller